Pulmonary Hypertension in SSc Patients Found to Shorten Survival

Pulmonary Hypertension in SSc Patients Found to Shorten Survival

307061

Pulmonary Hypertension in SSc Patients Found to Shorten Survival

Having pulmonary hypertension shortens survival in people with scleroderma, also called systemic sclerosis (SSc), according to a Brazilian study that followed patients for up to three years and used a computer algorithm to analyze the results. Specifically, this lower survival rate in SSc patients with pulmonary hypertension was particularly associated with a diagnosis of borderline pulmonary arterial hypertension (PAH) or interstitial lung disease (ILD) — a group of lung disorders in which the tissue in…

You must be logged in to read/download the full post.